London, December 2024 – CURESPONSE participated in the Tumour Models London Summit 2024, where Dr. Vered Bar, Vice President of R&D, delivered a featured session during the company’s hosted lunch titled:
“Future-Proofing Pipeline Compounds with Breakthrough Functional Technology.”
During the session, Dr. Bar presented CURESPONSE’s pioneering ex-vivo functional platform, designed to transform oncology drug development by providing deep, human-relevant insights into therapeutic response using intact patient-derived tumors.
Key Takeaways from the Session:
- The Science: CURESPONSE’s proprietary platform preserves the tumor and its microenvironment in a near-intact state, enabling highly predictive functional readouts.
- Differentiation: The platform delivers unmatched accuracy and translational relevance, allowing pharmaceutical and biotech partners to de-risk development programs and optimize decision-making.
- Pipeline Applications: The technology supports discovery and development across a broad range of modalities, including biologics, immuno-oncology therapies, antibody-drug conjugates (ADCs), and CAR-T cell therapies.
- Proven Impact: Case studies from leading pharmaceutical companies highlight the platform’s ability to improve pipeline efficiency and enhance clinical predictiveness.
- Ease of Collaboration: CURESPONSE offers a streamlined integration process, making it simple for partners to incorporate the platform into existing R&D workflows.
CURESPONSE is proud to be at the forefront of functional precision oncology, enabling smarter, faster, and more effective development of oncology therapies. The company thanks the Tumour Models London community for an engaging summit and looks forward to ongoing collaboration across the industry.
About CURESPONSE
CURESPONSE empowers pharmaceutical and biotech companies to accelerate and optimize oncology drug development through its unique ex-vivo functional platform. By testing real patient tumor samples, the platform provides actionable insights into treatment response, enabling data-driven decisions throughout the development pipeline